来源：经济导报 文|导报财经组 2月3日，小米集团（01810.HK）股价继续下探，报收于34.60港元/股，距离2026年第一个交易日收盘价下跌14.10%，距离去年9月25日股价次峰值（59.45 港元/股）下跌41.80%。 去年下半年以来，小米股价下跌备受市场关注。去年6月27日小米股价一度涨到61.45港元/股，当日收盘价为58.95港元/股，达到历史峰值，此后进入快速 下行通道，不到7个月时间股价近乎腰斩。 近期，小米集团又因"港元回购""美元减持"引发公众热议。 据了解，小米集团1月22日公告称，公司与一家独立经纪商订立协议。据此，经纪商将根据经纪协议所载之预定参数于香港联合交易所有限公司购回不超 过25亿港元的公司B类普通股。 对于本次回购的目的，小米集团表示，实施自动股份回购计划可展示公司对自身业务前景充满信心，符合公司及股东的整体最佳利益。 值得注意的是，去年12月28日，小米集团曾公告称，公司联合创始人、执行董事、副董事长林斌计划实施股份减持，累计减持公司B类普通股总金额不超 过20亿美元，减持所得款项将主要用于成立投资基金公司。 林斌是小米集团创业"七剑客"之一，2010年就开始与雷军 ...

Group 1 - The company has approved a plan to reduce its repurchased shares, allowing for a maximum reduction of 3,862,152 shares, which is up to 2% of the total share capital [1] - The reduction will be executed through centralized bidding transactions within six months from the announcement date, with the selling price determined by the market price at the time of sale [1] - As of January 31, 2026, the company has reduced 1,931,000 shares, representing 1.00% of the total share capital, with total proceeds amounting to 42,197,463.80 yuan, at an average price of 21.85 yuan per share [1]

利欧股份公告称，2025年10月15日公司董事会同意以集中竞价减持不超1.35亿股已回购股份（不超总股 本2%）。截至2026年1月31日，累计减持6700万股，占总股本0.99%，成交最高价6.77元/股，最低价 5.64元/股，均价6.01元/股，成交金额4.03亿元。本次减持计划实施有不确定风险，公司将按规定及时披 露信息。 ...

Core Viewpoint - Haier Biomedical (688139.SH) announced a share reduction plan by its shareholder, Qingdao Haichuangrui Equity Investment Fund Center, due to funding needs, intending to reduce up to 0.85% of its total shares, equating to a maximum of 2,690,189 shares [1] Group 1 - Haichuangrui plans to reduce its holdings in Haier Biomedical through centralized bidding, with a reduction period starting 15 trading days after the announcement and lasting for three months [1] - As of the last trading day before the announcement, Haier Biomedical's share price was 33.34 yuan per share, estimating the reduction amount to be approximately 89.69 million yuan [1] - Haichuangrui currently holds 32,103,659 shares of Haier Biomedical, representing 10.14% of the total share capital [1] Group 2 - Haichuangrui has signed a voting rights entrustment agreement with Haier Group, establishing a concerted action relationship [2] - Haier Group, through its controlled entity, Qingdao Haier Biomedical Medical Holdings, holds 100,591,463 shares, accounting for 31.78% of Haier Biomedical's total shares [2] - Another concerted action partner, Qingdao Haichuangzhi Management Consulting Enterprise, holds 8,675,900 shares, representing 2.74% of the total shares [2] Group 3 - Haier Biomedical was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 25, 2019, after receiving approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [3] - The company issued a total of 79,267,940 shares at a price of 15.53 yuan per share, raising approximately 1.23 billion yuan, with actual funds received amounting to about 1.16 billion yuan [3] - The funds were verified by Ernst & Young Hua Ming and were received on October 22, 2019, with Guotai Junan Securities serving as the lead underwriter [3]

Group 1 - Quzhou Dongfeng's controlling shareholder proposed to repurchase shares worth between 50 million to 100 million yuan for employee stock ownership plans or equity incentives [1] - Fushi Holdings' actual controller and chairman Chen Yongliang has been placed under detention by a national supervisory committee [2] - Chipone Technology's shareholder plans to reduce its stake by up to 1.95%, amounting to a maximum of 10.25 million shares due to personal funding needs [3] Group 2 - Leshan Electric reported a revenue of 3.395 billion yuan for 2025, a year-on-year increase of 6.24%, with a net profit of 23.4023 million yuan, up 3.68% [4] - Sanjia Technology plans to issue shares to its controlling shareholder to raise no more than 300 million yuan, with proceeds aimed at replenishing working capital and repaying bank loans [5] - GoerTek increased its share repurchase fund from a minimum of 500 million yuan to a range of 1 billion to 1.5 billion yuan [6] Group 3 - Hongbaoli clarified that it does not produce propylene oxide products, and its subsidiary's project is in the pre-production preparation stage [7] - Hunan Gold noted uncertainty regarding the future market price of its gold products despite recent price increases [8] - Great Wall Motors reported January sales of 90,300 vehicles, a year-on-year increase of 11.59% [9] Group 4 - Yanzhou Coal Mining announced the public transfer of 100% equity in Xintai Coal at a base price of 670 million yuan, which may significantly impact its net profit for 2026 [10] - Jerry Holdings signed a sales contract worth approximately 1.826 billion yuan with a U.S. client, representing 9.47% of its audited revenue for 2024 [11] - Fulongma pre-bid for four sanitation service projects in January, with a total first-year service fee of 83.5364 million yuan [12] Group 5 - China Unicom and China Telecom announced adjustments to the VAT applicable to their telecom services, which will affect their revenue and profits starting January 1, 2026 [13][17] - BAIC Blue Valley reported January sales of 8,073 vehicles, a year-on-year increase of 11.83% [19] - Penghui Energy submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [20] Group 6 - Haichuang Pharmaceutical passed the GMP compliance inspection for its soft capsule production line [21] - BGI Intelligent Manufacturing plans to acquire 100% equity in two companies for a total of 365.7 million yuan, aiming to integrate advanced technology platforms [22] - Jiamei Packaging's stock resumed trading after a suspension for volatility investigation [23] - Fenglong Co. also resumed trading following the completion of its stock trading suspension investigation [24]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603077 证券简称：和邦生物 公告编号：2026-007 债券代码：113691 债券简称：和邦转债 四川和邦生物科技股份有限公司 关于集中竞价减持公司已回购股份计划的公告 注：由于公司"和邦转债"已进入转股期，公告中涉及的比例计算以公司截至2026年1月28日总股本即 8,831,537,228股为基数计算。 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 回购股份的基本情况 为维护公司价值及股东权益，四川和邦生物科技股份有限公司（以下简称"公司"）于2024年4月至6月、 2024年6月至8月期间，通过集中竞价交易方式回购公司股份合计227,027,340股，占公司总股本的 2.57%。根据公司前期披露的相关回购股份方案，前述回购的股份将在披露回购结果暨股份变动公告12 个月后采用集中竞价交易方式出售，公司如未能在披露回购结果暨股份变动公告之后3年内实施前述用 途，尚未使用的部分将予以注销。具体内容详见公司在上海证券交易所网站（w ...

秦川物联公告称，2024年公司累计回购股份1043.69万股。2025 - 2026年，公司已通过集中竞价减持 223.18万股，占总股本1.33%，截至公告披露日，回购专用账户持股820.51万股，占总股本4.88%。公司 计划自公告披露之日起若干交易日后的三个月内（2026年3月2日 - 6月1日），集中竞价减持不超168万 股，占总股本1%，所得资金用于补充流动资金。若完成减持，回购专用账户持股比例将降至3.88%。减 持存在无法按计划完成的风险。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600884 证券简称：杉杉股份（维权） 公告编号：2026-002 宁波杉杉股份有限公司 关于已回购股份集中竞价减持计划的公告 本公司董事会、全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 经公司第十一届董事会第二十二次会议审议通过，公司计划自2026年2月26日至2026年5月25日期间，通 过集中竞价交易方式减持前期已回购股份不超过22,494,128股（即不超过公司总股本的1%），减持价格 按照市场价格确定。减持期间公司若有送股、资本公积金转增股本、股份回购注销等导致公司股本数量 变动的情形，减持数量将相应调整。减持股份所得资金将用于补充公司日常经营所需流动资金。 2026年1月27日，公司第十一届董事会第二十二次会议审议通过了《关于已回购股份集中竞价减持计划 的议案》，同意公司根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第7号一 一回购股份》等相关规定以及公司前期披露的回购股份方案约定，采用集中竞价交易方式减持公司已回 购的股份。本次减 ...

Core Viewpoint - The major shareholder of Tongfu Microelectronics, Huada Group, has reduced its stake in the company and decided to terminate its share reduction plan early after selling 15 million shares, which represents 0.99% of the company's total share capital, bringing its ownership down from 19.79% to 18.80% [1] Group 1: Shareholder Actions - Huada Group initiated its first share reduction on November 29, 2019, and has cumulatively reduced its holdings by 28.7 million shares, realizing approximately 507 million yuan [2] - The recent share reduction occurred between January 21 and January 23, 2026, with an average selling price of 56.04 yuan per share, resulting in a cash inflow of 841 million yuan [1] Group 2: Fundraising Activities - Tongfu Microelectronics plans to raise up to 4.4 billion yuan through a private placement of A-shares, with the funds intended for enhancing testing capacity in storage chips, automotive applications, and other emerging fields, as well as for working capital and repaying bank loans [2] - Over the past six years, Tongfu Microelectronics has raised a total of 5.965 billion yuan [5]

Core Viewpoint - The actual controller of Shenzhen Yuanwanggu Information Technology Co., Ltd., Xu Yusuo, plans to reduce his shareholding in the company, which has implications for the company's ownership structure and potential market reactions [2][3]. Group 1: Shareholding Changes - On December 19, 2025, Xu Yusuo announced intentions to reduce his shareholding by up to 22,192,722 shares, representing 3% of the total share capital [2]. - As of January 15 to January 22, 2026, Xu Yusuo reduced his holdings by 5,289,616 shares, bringing his total to 100,832,897 shares, which is 13.63% of the total share capital [3]. - On January 23, 2026, he further reduced his holdings by 3,031,303 shares, resulting in a total of 97,801,594 shares, or 13.22% of the total share capital [3]. Group 2: Pledge of Shares - As of January 23, 2026, the share pledge situation for Xu Yusuo and his concerted actor, Chen Guangzhu, indicates that 9,322,000 shares are pledged, which is 70.27% of their total holdings and 12.60% of the total share capital [5]. - The financing balance corresponding to the pledged shares is 29,490 million [5]. - There are currently no risks of forced liquidation or transfer of pledged shares, and the pledge risk is considered manageable [6].